CAVALLO PERIN, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 13.377
EU - Europa 9.268
AS - Asia 2.994
SA - Sud America 96
OC - Oceania 77
AF - Africa 56
Continente sconosciuto - Info sul continente non disponibili 12
Totale 25.880
Nazione #
US - Stati Uniti d'America 13.120
DK - Danimarca 3.064
CN - Cina 1.915
IT - Italia 1.101
IE - Irlanda 923
DE - Germania 766
FR - Francia 686
SE - Svezia 634
FI - Finlandia 502
UA - Ucraina 441
KR - Corea 426
GB - Regno Unito 331
AT - Austria 241
PL - Polonia 240
CA - Canada 229
VN - Vietnam 151
JP - Giappone 89
IN - India 81
BE - Belgio 74
ES - Italia 63
AU - Australia 62
ID - Indonesia 58
BR - Brasile 44
NL - Olanda 42
TW - Taiwan 41
TR - Turchia 40
HK - Hong Kong 33
CH - Svizzera 29
SG - Singapore 26
IR - Iran 25
RU - Federazione Russa 25
PH - Filippine 23
MX - Messico 20
SN - Senegal 20
GR - Grecia 16
MY - Malesia 16
NZ - Nuova Zelanda 15
TH - Thailandia 15
CO - Colombia 14
NO - Norvegia 14
UZ - Uzbekistan 14
PE - Perù 13
AR - Argentina 12
RO - Romania 12
EU - Europa 11
HU - Ungheria 10
PT - Portogallo 10
SA - Arabia Saudita 8
CZ - Repubblica Ceca 7
EG - Egitto 7
BG - Bulgaria 6
CL - Cile 6
IL - Israele 6
PK - Pakistan 5
RS - Serbia 5
ZA - Sudafrica 5
MK - Macedonia 4
NG - Nigeria 4
DZ - Algeria 3
EE - Estonia 3
IQ - Iraq 3
JM - Giamaica 3
KE - Kenya 3
LT - Lituania 3
LU - Lussemburgo 3
MA - Marocco 3
UY - Uruguay 3
AM - Armenia 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
GH - Ghana 2
GT - Guatemala 2
HR - Croazia 2
IM - Isola di Man 2
IS - Islanda 2
MD - Moldavia 2
MO - Macao, regione amministrativa speciale della Cina 2
PS - Palestinian Territory 2
QA - Qatar 2
VE - Venezuela 2
A1 - Anonimo 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CM - Camerun 1
CY - Cipro 1
ET - Etiopia 1
GE - Georgia 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
MC - Monaco 1
MM - Myanmar 1
MU - Mauritius 1
MZ - Mozambico 1
PA - Panama 1
SC - Seychelles 1
Totale 25.874
Città #
Ann Arbor 4.819
Beijing 1.309
Chandler 1.098
Dublin 911
Houston 579
Wilmington 492
Ashburn 445
Villeurbanne 419
Fairfield 370
Jacksonville 364
Princeton 351
Dearborn 331
Woodbridge 317
Medford 272
Vienna 238
Nyköping 231
Warsaw 220
Seattle 209
Redwood City 201
Torino 182
Munich 144
Cambridge 128
Fremont 127
Boston 119
Milan 117
Pisa 111
Dong Ket 107
Montréal 104
Palaiseau 94
Grafing 84
Boardman 70
Brussels 61
Hefei 57
Menlo Park 56
New York 53
Shanghai 53
Toronto 53
Verona 50
Guangzhou 44
Nanjing 43
Hangzhou 41
Kunming 41
Düsseldorf 40
Norwalk 39
Falls Church 36
Rome 31
San Diego 29
Nanchang 27
Phoenix 27
Taipei 27
Turin 26
Tokyo 24
Mountain View 23
Des Moines 20
Helsinki 20
Jakarta 20
Lachine 20
London 20
Chengdu 19
Jinan 19
Central District 18
Changsha 18
Detroit 18
Pune 18
Istanbul 16
Ottawa 16
Padova 16
Silver Spring 16
Washington 16
Wuhan 16
Chongqing 14
Duncan 14
Lima 13
Madrid 13
Zhengzhou 13
Bologna 12
Edinburgh 12
San Francisco 12
Chicago 11
Hanoi 11
Hebei 11
Shenyang 11
Frankfurt am Main 10
Fuzhou 10
Los Angeles 10
San Mateo 10
Trieste 10
Costa Mesa 9
Kuala Lumpur 9
São Paulo 9
Zurich 9
Amsterdam 8
Berlin 8
Catania 8
Xian 8
Bari 7
Groningen 7
Kumar 7
Las Vegas 7
Redmond 7
Totale 16.050
Nome #
Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial 714
Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes 412
Human mesenchymal stem cell-derived microvesicles modulate T cell response to islet antigen glutamic acid decarboxylase in patients with type 1 diabetes 407
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 400
Impact of Snacking Pattern on Overweight and Obesity Risk in A Cohort of 11-13-y Adolescents 392
Diabetes-specific variables associated with quality of life changes in young diabetic people: the type 1 diabetes Registry of Turin (Italy) 345
Prediction of mortality and macrovascular complications in type 2 diabetes: validation of the UKPDS Outcomes Model in the Casale Monferrato survey, Italy. 341
Joint use of cardio-embolic and bleeding risk scorers in elderly patients with atrial fibrillation. 292
Hippocampal heat shock protein 25 expression in streptozotocin-induced diabetic mice. 277
Urinary Exosomal MicroRNAs in Incipient Diabetic Nephropathy 275
Anti-heat shock protein 27 antibody levels and diabetes complications in the EURODIAB study 242
Contributors to the obesity and hyperglycemia epidemics. A prospective study in a population-based cohort. 238
Circulating anti-Hsp70 levels in nascent metabolic syndrome: the Casale Monferrato Study. 223
Direct costs of diabetic and non diabetic people: the population-based Turin study. 222
NT-proBNP Linking Low-Moderately Impaired Renal Function and Cardiovascular Mortality in Diabetic Patients: The Population-Based Casale Monferrato Study 220
The Effect of Age and NT-proBNP on the Association of Central Obesity with 6-Years Cardiovascular Mortality of Middle-Aged and Elderly Diabetic People: The Population-Based Casale Monferrato Study 216
Serum levels of heat shock protein 27 in patients with acute ischemic stroke 209
Activated protein C resistance in type I diabetes. 200
What is the impact of sleeve gastrectomy and gastric bypass on metabolic control of diabetes? A clinic-based cohort of Mediterranean diabetic patients 194
Anti-HSP70 levels and the metabolic syndrome: the Casale Monferrato Study 188
Urinary exosomal microRNA signature in incipient diabetic nephropathy 188
Association between serum heat shock proteins and anti-heat shock proteins levels with micro/macrovascular complications in type 1 diabetes: the EURODIAB Prospective Complications Study 187
Albumin excretion rate levels in non-diabetic offspring of NIDDM patients with and without nephropathy. 187
Albumin excretion rate is not increased in atherosclerotic patients with peripheral vascular disease. 186
Effetti dello stress meccanico (stretch) combinato all’alto glucosio sulla proliferazione, l’apoptosi e la morfologia dei periciti retinici. 184
Serum heat shock protein 27 is a new circulating biomarker for hepatocellular carcinoma 182
Anti-angiogenic and immunomodulatory effects of rapamycin on pancreatic islet endothelial cells: relevance for islets engraftment after transplantation 181
Associazione tra anti-HSP70 e sindrome plurimetabolica: il Casale Monferrato Study 181
N-terminal probrain natriuretic peptide is a stronger predictor of cardiovascular mortality than C-reactive protein and albumin excretion rate in elderly patients with type 2 diabetes: the Casale Monferrato population-based study. 181
Anticoagulant protein C activity in non-insulin-dependent diabetic patients with normoalbuminuria and microalbuminuria 180
Monocyte Chemoattractant Protein-1 (MCP-1) has direct prosclerotic effects in human mesangial cells 179
Silicone lymphadenopathy after silent Silicone breast implant rupture 179
ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB Study 179
Apolipoprotein H is increased in type 2 diabetic patients with microalbuminuria. 178
Anticoagulant protein C in type II diabetic patients with and without microalbuminuria 176
Ruolo protettivo del recettore CB2 nella nefropatia diabetica sperimentale 175
Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy 174
Il sistema MCP-1/CCR2 nelle cellule mesangiali umane: modulazione da stretch e ruolo nell’espressione di ICAM-1 173
Protective role of cannabinoid receptor type-2 in a mouse model of diabetic nephropathy 172
Urinary excretion of glycated albumin in insulin-dependent diabetic patients with micro- and macroalbuminuria. 171
Effetti dello stress meccanico (stretch) sulla proliferazione cellulare nei periciti retinici bovini in alto glucosio. 171
Effects of mechanical stress and high glucose on pericyte proliferation, apoptosis and contractile phenotype 171
Early life socioeconomic indicators and the risk of type 1 diabetes in children and young adults 171
Albumin excretion rate in non diabetic offspring of type 2 diabetic patients 170
MORTALITY OUTCOMES OF DIFFERENT SULFONYLUREA DRUGS. The results of a 14-year cohort study of type 2 diabetic patients 167
Espressione delle proteine dello slit DIAPHRAGM in animali diabetici knockout per il monocyte chemoattractant protein-1. 166
Retinal heat shock protein 25 in early experimental diabetes 164
Lipoprotein(a) after acute exercise in healthy subjects. 163
Uric acid is not an independent predictor of cardiovascular mortality in type 2 diabetes: a population-based study 163
Effect of the MCP-1/CCR2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes 162
ATTIVAZIONE DEL RECETTORE CB2 E NEFROPATIA DIABETICA SPERIMENTALE 160
The glucoregulatory and antilipolytic actions of insulin in abdominal obesity with normal or impaired glucose tolerance: an in vivo and in vitro study. 160
The MCP-1/CCR2 system has direct proinflammatory effects in human mesangial cells 159
Increased QT interval dispersion predicts 15-years cardiovascular mortality in type 2 diabetic subjects. The population-based Casale Monferrato Study 159
Serum heat shock protein 27 levels in patients with hepatocellular carcinoma. 159
High-normal blood pressure and impaired renal function. A prospective study in a population-based cohort. 159
Effect of CB2 receptor deletion in streptozotocin-induced diabetic mice 157
Trombomodulin is increased in microalbuminuric insulin dependent diabetic patients 157
Incidence and risk factors of prolonged QTc interval in type 1 diabetes: the Eurodiab Prospective Complications Study 156
The Monocyte Chemoattractant Protein-1/Cognate CC Chemokine Receptor 2 System Affects Cell Motility in Cultured Human Podocytes 156
Effetti dello stress meccanico(stretch) combinato con l’alto glucosio sulla proliferazione, l’apoptosi e la morfologia dei periciti retinici. 155
Increased retinal HSP27 expression in early experimental diabetes 155
Effect of CB2 Receptor Activation in Experimental Diabetic Nephropathy 154
Thrombomodulin levels in insulin-dependent diabetic patients with microalbuminuria 154
Increased levels of platelet-activating factor in insulin-dependent diabetic patients with microalbuminuria 153
Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy. 152
Effect of age on the association of non-high-density-lipoprotein cholesterol and apolipoprotein B with cardiovascular mortality in a Mediterranean population with type 2 diabetes: the Casale Monferrato study 152
Effects of mechanical stress (stretch) combined with high glucose on retinal pericyte replication, apoptosis and morphology. 152
NH2-Terminal Probrain Natriuretic Peptide Is Associated With Diabetes Complications in the EURODIAB Prospective Complications Study: The role of tumor necrosis factor-α 152
Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells 151
Effects of CB1 Blockade In Experimental Diabetic Nephropathy 151
Heat shock protein expression in early diabetic nephropathy 151
Serum glucose, insulin, C-peptide and plasma glucagon response to oral glucose after intravenous injection of different glucocorticoids at increasing doses in man 151
Microalbuminuria in IDDM is associated with increased expression of monocyte procoagulant activity. 150
Obesity is associated with lower mortality risk in elderly diabetic subjects: the Casale Monferrato study. 150
Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study. 150
N-terminal pro-brain natriuretic peptide and cardiovascular mortality in type 2 diabetes: the Casale Monferrato survey. 150
Espressione delle Heat Shock Proteins nella nefropatia diabetica sperimentale 150
PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria 149
Electrocardiographic left ventricular hypertrophy in type 1 diabetes. Prevalence and relation to coronary heart disease and cardiovascular risk factors: The Eurodiab IDDM Complications Study 148
Serum heat shock protein 27 and diabetes complications in the EURODIAB prospective complications study: a novel circulating marker for diabetic neuropathy 148
Effects of mechanical stress (stretch) combined with high glucose on retinal pericyte replication, apoptosis and morphology. 148
Serum glucose, insulin and C-peptide response to oral glucose after intravenous administration of hydrocortisone and methylprednisolone in man 148
Microalbuminuria and plasma endothelin-1 in non insulin dependent diabetes mellitus 147
QTc Interval Prolongation Is Independently Associated With Severe Hypoglycemic Attacks in Type 1 Diabetes From the EURODIAB IDDM Complications Study 147
Coagulation inhibitors in type 2 diabetic patients with and without microalbuminuria 146
Heat shock protein expression in diabetic nephropathy 145
The MCP-1/CCR2 system in human mesangial cells: modulation by stretch and role in ICAM-1 expression 144
Plasma beta-thromboglobulin and platelet factor 4 are not increased in insulin-dependent diabetic patients with microalbuminuria 144
Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology 143
Microalbuminuria in insulin-dependent diabetes is associated with high levels of prothrombin fragment 1 + 2 143
Microalbuminuria in insulin-dependent diabetes is associated with monocyte procoagulant activity 143
Lipoprotein(a) in non-insulin-dependent diabetic patients with normo- and microalbuminuria 142
Haemostatic alterations in microalbuminuric insulin dependent diabetic patient 140
La dolce Vita. Per un Museo del Diabete. FONDAZIONE DIABETE TORINO - ONLUS 140
Il blocco del recettore CB1 nella nefropatia diabetica sperimentale 137
Lipoprotein(a) and insulin treatment in non insulin dependent diabetic patients 136
Stretch reduces nephrin expression via an angiotensin II-AT(1)-dependent mechanism in human podocytes: effect of rosiglitazone 136
Response to Comment on: Gruden et al. Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study. Diabetes Care 2012;35:1598-1604. 134
Lipoprotein(a) and insulin treatment in NIDDM patients 134
Totale 18.725
Categoria #
all - tutte 56.713
article - articoli 0
book - libri 0
conference - conferenze 13.897
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.610


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019787 0 0 0 0 0 0 0 0 73 209 357 148
2019/20206.007 92 85 652 399 685 1.161 486 208 229 424 775 811
2020/20212.832 651 97 138 93 190 138 175 89 291 202 105 663
2021/20225.951 587 467 512 731 456 499 630 558 404 99 424 584
2022/20233.855 554 195 58 285 337 970 438 294 359 63 240 62
2023/20241.159 193 238 72 89 107 203 47 195 15 0 0 0
Totale 27.009